I thought your 5yr old came up with that

The fda didn’t specify what kind of testing they wanted done in that meeting. Only specific testing. That leaves it wide open for speculation on what they wanted.

It was only last year that the fda told radiogel specifically what kind of testing they would like done.

Nice try though.

Little hints here and there without actually telling us that they are moving forward already.

That’s how I’m reading it. Rabbits are ready to go. It’s all on JHU now

Green on a Monday, good start let’s see what the rest of the week will bring.

Hopefully they will tweet a estimate timeline on the rabbits in the next few days.

This very well could happen maybe on two fronts, one a partnership with isopet and a partnership with radiogel.

Since they are technically separate so why not.

Moderators post the update on the sticky

Not going to lie, I was hoping for a timeline, but regardless still a very good pr.

I appreciate your professional input and your time frames. Much more realistic than anyone else’s especially since most of us have no clue what this all involves.

Don’t waste your time.

Over all a very good pr/update.

Lower shipping costs, extra protection on the product itself.

More patent protections

Rabbits ready to go.

3rd party in place.

Next update should be a time frame, maybe.

Good way to start the year

Sounds like they can start the testing any day now.

Must be pretty good stuff if they are putting out a pr first thing tomorrow morning.

The doctor has always thought there would be a potential buyout before human testing would begin, mainly because a larger company has the funds to easily afford the human testing phases which can be time consuming and very expensive.

Something he said a long time ago is that he would be very open to a buyout.

Time will tell, possibly a buyout if ide is approved

My opinion if a buyout happens it will be between the 2nd and 3rd phases.

Someone woke up on the wrong side of the bed

Actually yes you have said on several occasions that it’s going to .03

Ditto

200000 at .044 nice buys

Vivos Inc Initiates Isopet® Therapy in Horses

Press Release | 06/24/2021

Richland WA, June 24, 2021 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL) Vivos Inc announced that it has completed the first IsoPet® therapy on an equoid tumor. It was administered at the University of Missouri on a horse that was transported from Ohio. This is an exciting extension of Isopet®, offering an important and unique treatment alternative for larger animals such as horses. The procedure was conducted under mild sedation with a therapy design that, as always, results in no contamination. This first patient is doing well and already the tumor has stopped growing.

Dr. Mike Korenko stated, “Expanding Isopet® into the equine market is an important expansion of the Vivos’ business plan. Treating large tumors in large animals is an area in which IsoPet® is uniquely suited. We intend to further refine the technique with the next few animals and then to collaborate with a private clinic in either Kentucky or Texas.

Owners of potential equine patients are now eligible to complete our new Expression of Interest form specifically for equine therapy under IsoPet Therapy on our web page www.RadioGel.com.”

About Vivos Inc. (OTCQB: RDGL)

Vivos Inc. has developed an Yttrium-90 based injectable brachytherapy device, for the treatment of tumors in animals (IsoPet®) and in humans (RadioGel™). Brachytherapy uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area using the company’s proprietary hydrogel technology. The injection delivers therapeutic radiation from within the tumor without the entrance skin dose and associated side effects of treatment that characterize external-beam radiation therapy. This feature allows safe delivery of higher doses needed for treating both non-resectable and radiation-resistant cancers.

RadioGel™ is a hydrogel liquid containing tiny yttrium-90 phosphate particles that may be administered directly into a tumor. The hydrogel is an yttrium-90 carrier at room temperature that gels within the tumor interstitial spaces after injection to keep the radiation sources safely in place. The short-range beta radiation from yttrium-90 localizes the dose within the treatment area so that normal organs and tissues are not adversely affected.

RadioGel™ also has a short half-life – delivering more than 90% of its therapeutic radiation within 10 days. This compares favorably to other available treatment options requiring up to six weeks or more to deliver a full course of radiation therapy. Therapy can be safely administered as an out-patient procedure and the patient may return home without subsequent concern for radiation dose to family members.

The IsoPet® Solutions division used university veterinary hospitals to demonstrate the safety and therapeutic effectiveness for different animal cancers. Testing on feline sarcoma at the Washington State University was completed in 2018 and testing on canine soft tissue sarcomas at the University of Missouri was completed in 2019.

In 2018 the Company obtained confirmation from the FDA Center for Veterinary Medicine that IsoPet® is classified as a medical device according to its intended use and means by which it achieves its intended purpose. The FDA also reviewed the product labeling which included canine and feline sarcomas as the initial indications for use. The FDA does not require pre-market approval for veterinary devices so no additional approval is required. Following the demonstration phase, Vivos is able to generate revenue through the sale of IsoPet® to University animal hospitals and private veterinary clinics.

IsoPet® for treating animals uses the same technology as RadioGel™ for treating humans. The Food and Drug Administration advised using different product names in order to avoid confusion and cross-use.

CONTACT:

Vivos Inc.
Michael K. Korenko, Sc.D.
President & CEO
MKorenko@RadioGel.com

Safe Harbor Statement

This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.

CONTACT:

Vivos Inc.
Michael K. Korenko, Sc.D.
President & CEO
MKorenko@RadioGel.com

110000 buy at 42 lucky guy

If the rabbits were just ordered then the cancer cells must be just about ready.

Honestly surprised you got that from him

I agree. I just hope people don’t go on a selling frenzy during the submittal

With what people have posted and including the doctor, about 12 people have 1/6 of the float.

I’m sure there’s other share holders that have more and including us small holders.

I would have to say at least half the shares are locked up in long hands. Possibly closer to 60%.

Ide submittal hits this will go bonkers. Approval even higher depending on how everyone plays their hand.

Lol, tell your friend to lay off of the drugs.

Lol, that’ll work for me

Interesting that the doc bought today, not that I’m complaining it’s definitely a positive sign. Paperwork was done in the same day as well and posted the same day, usually it takes a couple of days before they post the form.

Throwing it out there news tomorrow possibly Monday.

Nice

Hmmm some one bought on the high side.

Yes indeed, you are one of the few here that knows the true potential of this play.
This will be an epic play in time. As long as the fda doesn’t railroad them and give some bs excuse not to approve.

Regardless of platform, he’s just one big player that we know of. There’s plenty more including the brokerages that can’t buy in until a certain price range.

So ide submittal is going to shock a lot on this board how high this is going to reach, with approval even higher, announcing the start of human testing even higher. Yes there will be pullbacks along the way but this will be an epic play. My own opinion of course.

I wasn’t talking about twitter

Oh I guarantee he’s watching this like a hawk and in constant contact with the doctor. Ide submittal you will see a lot of action. He has some 2000 followers and that’s just the ones that actually admit they follow him.

With the ise approach just by going that route alone it’s a 75-80 percent chance of approval. If the rabbit testing shows 100 percent containment this is a shoe in for approval. This news hits the wire this will start moving before the ide is even submitted.

Again the request for more animal testing didn’t come up until the second meeting with the fda, in that meeting there was 8 new board members that had no clue what radiogel even was.

Again your information about the animal testing is wrong. Quit posting that information that is wrong.

There’s not one company out there that’s going to spend money on testing until they are required and or requested to do so. Mainly because they have no idea what the fda is looking for specifically and what protocols that they will have to follow.

People are keeping this down, isopet is regularly putting out good news, vivos is doing the same. This should be sitting at or around .10cents.

Rtg, with them having to write a second amendment, would they have to resubmit their plan to the agency that deals with whether or not the animals in the study will be treated humanely.

Again more animal testing wasn’t requested until the second fda meeting.

Rabbit testing was not requested until the second meeting with the FDA. In that second meeting 8 out of the 11 board members were new and new nothing about radiogel until they sat in that meeting. With the new members of the board requested the rabbit testing and at that time as far as we know the request was for only one rabbit test

If there wasn’t 8 new members on the board they would not have requested the rabbit test more then likely.

At the 3rd meeting they requested that 10 rabbits be tested on. Regardless they approved the plan to move forward.

After this they had to submit there plan to another agency regarding how the rabbits are taken care and make sure that they are treated humanely. Here in this meeting they requested to split the testing up and requested a 2nd amendment. The 1st amendment was approved what we don’t know is if they had to resubmit the 2nd amendment so it could be read and gone through and need to be approved. If so then hopefully they already resubmitted the 2nd amendment and are waiting for the review meeting.


I’m sure I missed something or have something backwards this just of the top of the head.
so everyone go ahead and add what you remember. Ex

Actually no you don’t always state facts.

Remember whether you like the guy or not George Sharp is still following this and guarantee you that at minimum 20-30 percent of his followers are as well. He has well over 2000 followers.

That’s only one big hitter and his followers.

Wouldn’t be surprised if after the first of the year we see a uptick in shares and price.

Most traders are looking at their end of year earnings and tax right offs and looking to see what’s going to run first part of next year.

January/February always seems to be a little slow in the otc unless big news hits.

My opinion we are in this range until about mid to end of January. This all depends if we have a time frame for the animal testing as well.

I’m with cat on-this, this is a easy .50 and I’m going to say plus on the ide submittal alone

I don’t mind everyone being conservative on what the price action will be when they submit and get approved.

Bdd submittal took this to a high of .31.

You all have to remember, there’s lots of eyes on this sitting on the sidelines. There’s also brokerages that can’t invest until a certain price.

Now they have the Mayo Clinic and John’s Hopkins vet hospital as well. There’s plenty of proof this works and is a thousand times better than the seed treatment.

Submittal will hit a lot higher this time just because of who’s helping and the testing they have completed and the proof they have with all of the animals they have treated already.

I’m looking at .30-.50 for a high with submittal then swinging back and forth with Approval will bring a dollar plus.


Then this will go higher once they announce start of first phase human testing.

If a buyout happens it probably won’t happen until after approval of phase 2.

By the time this all happens I wouldn’t be surprised to see isopet running pretty hard as well and possibly being used over seas by then.

Time will tell but regardless of what anyone thinks what this will do. It will be running on ide submittal. What the price action will actually do well it’s going to go up and pretty high.

My opinion, it’s up in the air. With having to write up a second amendment, I imagine that they had to resubmit the the plan to that organization that makes sure the animals are treated right.

If that’s the case hopefully they were able to do the write up and get it sent in by the first of December. If they did hopefully they hear something around the 17th of December. It looked like they meet once a month to go over the submissions.

Anyway if this is the case and they do get approval for the second amendment. Around the 17th. It’ll then be up to how fast they can grow the cancers and get the 10 rabbits. If by some chance they already started growing the cancers they possibly could be ready to start shortly after the first of the year. Don’t forget they need to have the 3rd party lined up as well.

So it’s very pointless we could get some time line’s when they release the monthly update, granted they may skip the monthly and just do one major update for year end and what they are planning for 2023.

So literally up in the air what we will hear.